Literature DB >> 9699025

Oxidant-antioxidant imbalance in blood of children with juvenile rheumatoid arthritis.

V Araujo1, C Arnal, M Boronat, E Ruiz, C Domínguez.   

Abstract

Juvenile rheumatoid arthritis (JRA) is the most commonly diagnosed rheumatic disease in children and may represent not a single disease, but rather a syndrome of diverse aetiologies in which inflammation is an exceedingly complex process. Oxidative free radical production at inflammation sites contributes to tissue damage and could also play a significant role in the pathogenesis of JRA. The aim of this study was to evaluate the antioxidant status and lipid peroxidation parameters related to the clinical form of JRA. Plasma malondialdehyde and hydroperoxide concentrations in children with polyarticular and systemic JRA subtypes were significantly higher than in controls. Plasma vitamin E and beta-carotene levels of the JRA children were lower in the three forms compared with healthy children. Patients with JRA present an imbalance in the oxidant-antioxidant system that manifests clearly in the polyarticular and systemic forms through an increase in lipoperoxidation products and significant decrease in the lipid-soluble antioxidants vitamin E and beta-carotene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699025     DOI: 10.1002/biof.5520080126

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  7 in total

1.  Oxidative status in rheumatoid arthritis.

Authors:  Yesim Ozkan; Sevgi Yardým-Akaydýn; Aylin Sepici; Erinc Keskin; Vesile Sepici; Bolkan Simsek
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

Review 2.  Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

3.  Autoimmune reactivity of IgM acquired after oxidation.

Authors:  Jasna Omersel; Ivica Avberšek-Lužnik; Pegi Ahlin Grabnar; Tanja Kveder; Blaž Rozman; Borut Božič
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

4.  Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.

Authors:  Yasunori Kageyama; Masaaki Takahashi; Tetsuyuki Nagafusa; Eiji Torikai; Akira Nagano
Journal:  Rheumatol Int       Date:  2007-07-28       Impact factor: 2.631

5.  The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis.

Authors:  Jelena Bašić; Jelena Vojinović; Tatjana Jevtović-Stoimenov; Milena Despotović; Tatjana Cvetković; Dragana Lazarević; Gordana Sušić; Vuk Milošević; Mina Cvetković; Dušica Pavlović
Journal:  Rheumatol Int       Date:  2019-01-24       Impact factor: 2.631

6.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis.

Authors:  James N Jarvis; Igor Dozmorov; Kaiyu Jiang; Mark Barton Frank; Peter Szodoray; Philip Alex; Michael Centola
Journal:  Arthritis Res Ther       Date:  2003-11-06       Impact factor: 5.156

7.  Beta-Carotene, Vitamin E, MDA, Glutathione Reductase and Arylesterase Activity Levels in Patients with Active Rheumatoid Arthritis.

Authors:  N Aryaeian; M Djalali; F Shahram; Sh Jazayeri; M Chamari; Sa Nazari
Journal:  Iran J Public Health       Date:  2011-06-30       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.